A new mobile app, Pocket Voice Lab, offers real-time biofeedback for voice training, targeting transgender individuals and voice professionals. Development is ongoing.
Browsing Category
Healthcare operations
25 posts
Deepening Collaboration In AI-Powered R&D Acceleration: Insilico Medicine And CMS Announce Additional Collaborations In CNS Diseases
Insilico Medicine and CMS announce increased partnership to accelerate AI-driven research in central nervous system diseases, marking a significant step in biotech innovation.
2026 Alzheimer’s Association Conference Announced
The 2026 International Conference of the Alzheimer’s Association has been officially scheduled, focusing on latest research and treatment advances.
Rhythm Pharmaceuticals Announces The New England Journal Of Medicine Publication Of Phase 3 TRANSCEND Trial Results In Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals announced the publication of its Phase 3 TRANSCEND trial results on acquired hypothalamic obesity in the New England Journal of Medicine.
As Ebola Surges, 3 In 4 Americans Back Restoring U.S. Aid To Fight It, Per New Echelon-Rockefeller Foundation Poll
New poll shows 75% of Americans favor restoring U.S. aid as Ebola cases increase globally, highlighting public concern and policy implications.
Women’s Health Radar
A new digital health app aims to identify early signs of perimenopause in women 40-58, potentially improving diagnosis and care access.
HelloNation Article Featuring Dermatology Expert Dr. Hannah Pederson Explains What To Do When A Rash Will Not Go Away
Dr. Hannah Pederson discusses causes and treatments for stubborn rashes that do not resolve, emphasizing importance of medical evaluation.
Retirement Care Planner
A new web app prototype aims to help adult children coordinate care and finances for aging parents, addressing rising costs and complex decisions.
AI compliance brief generator for small clinics
A new AI tool designed for small clinics to generate weekly compliance briefs is entering testing, aiming to streamline regulatory monitoring for healthcare providers.
Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
Partner Therapeutics announced the publication of trial results showing Zenocutuzumab’s effects in NRG1+ cholangiocarcinoma in the Journal of Clinical Oncology.